Dihydromyricetin attenuates age-related macular degeneration: pharmacological effects and exploration of putative targets
IntroductionAge-related macular degeneration (AMD) is a leading cause of vision loss in older adults, with limited effective treatments available. This study aimed to investigate the pharmacological effects of dihydromyricetin (DHM) on AMD and to identify its putative pharmacological targets through...
Saved in:
| Main Authors: | Hongyu Zhou, Jianhui Pang, Baiyang Wu, Yanan Zhuang, Shenjun Li, Jing Jiang |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-08-01
|
| Series: | Frontiers in Pharmacology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2025.1588970/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Etiopathogenesis of non-exudative age-related macular degeneration (literature review)
by: M. M. Bikbov, et al.
Published: (2022-03-01) -
Real-World 5-Year Outcomes of Age-Related Macular Degeneration with Bevacizumab as First-Line Anti-VEGF
by: H. Mhmud, et al.
Published: (2025-06-01) -
Antioxidants in Age-Related Macular Degeneration: Lights and Shadows
by: Uday Pratap Singh Parmar, et al.
Published: (2025-01-01) -
Berries and Their Active Compounds in Prevention of Age-Related Macular Degeneration
by: Xiang Li, et al.
Published: (2024-12-01) -
Efficacy and Safety of Nutraceutical Support in Age-Related Macular Degeneration Patients
by: S. V. Yanchenko, et al.
Published: (2023-01-01)